Allergan Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 4,403.4 | 3,938.9 | 3,063.3 |
| Cost of Goods Sold | 761.2 | 673.2 | 575.7 |
| Gross Profit | 3,642.2 | 3,265.7 | 2,487.6 |
| Gross Profit Margin | 82.7% | 82.9% | 81.2% |
| SG&A Expense | 1,856.0 | 1,680.1 | 1,333.4 |
| Depreciation & Amortization | 150.9 | 121.3 | 79.6 |
| Operating Income | 847.8 | 759.1 | 40.7 |
| Operating Margin | 19.3% | 19.3% | 1.3% |
| Nonoperating Income | 18.2 | (25.6) | (5.0) |
| Nonoperating Expenses | (27.1) | -- | -- |
| Income Before Taxes | 787.2 | 687.7 | (19.5) |
| Income Taxes | 207.0 | 186.2 | 107.5 |
| Net Income After Taxes | 580.2 | 501.5 | (127.0) |
| Continuing Operations | 578.6 | 501.0 | (127.4) |
| Discontinued Operations | 0.0 | (1.7) | -- |
| Total Operations | 578.6 | 499.3 | (127.4) |
| Total Net Income | 578.6 | 499.3 | (127.4) |
| Net Profit Margin | 13.1% | 12.7% | -- |
| Diluted EPS from Total Net Income ($) | 1.89 | 1.62 | (0.44) |
| Dividends per Share | 0.20 | 0.20 | 0.20 |
© 2009 Morningstar, Inc. Financial Data provided by
